Every pharmaceutical manufacturer in the UAE depends on imported active pharmaceutical ingredients. Since the 2025 law, the rules that govern how APIs enter the country sit with the Emirates Drug Establishment (EDE). This briefing sets out who may import APIs, what the EDE expects from a source, and how a compliant consignment cycle runs in practice.
Who regulates API imports now
Under the UAE pharmaceutical law in force from 2025, the Emirates Drug Establishment (EDE) is the federal authority for import and export permits, pharmaceutical facility licensing (including medical warehouses), manufacturing site registration, and GMP and GDP oversight. These functions transferred from the Ministry of Health and Prevention (MOHAP).
For an API buyer, the practical consequence is consolidation. The permit that clears your raw material, the licence behind the warehouse that receives it, and the good practice standards that govern its storage now all sit with one federal authority. That makes the sequence easier to plan, but it also means a gap anywhere in the chain surfaces quickly.
Who may import an API
The rule is strict. Only entities holding a UAE pharmaceutical facility or medical warehouse licence, with the corresponding EDE import permit, may import pharmaceuticals, medical devices, and APIs. There is no informal route around this: an API consignment arriving without a licensed importer behind it has no legal basis to enter.
A manufacturer with its own licensed facility can import against that licence, provided it obtains a permit for each consignment. A manufacturer that prefers not to run importation in house has a second route: a licensed importer brings the material in and delivers it to the site. We hold our own licensed pharmaceutical facility, medical warehouse, and importer credentials, and our API import and registration service runs that route end to end.
What the EDE expects from an API source
An API cannot be selected on price alone. The source itself needs a documented regulatory standing before material moves. In practice, that means the API site should hold a Drug Master File (DMF) or a Certificate of Suitability (CEP), together with GMP evidence for the manufacturing site. We review this documentation before any purchase commitment, because a weak source file tends to resurface later as a blocked permit or a query against the finished product dossier.
Qualifying a source early also protects the production schedule. Changing an API supplier after a finished product is registered is a regulatory exercise, not a procurement one, so the cheapest time to get the source right is before the first order is placed. Where a client is choosing between two candidate sites, we compare the documentation packages alongside the commercial terms and say plainly which file is stronger.
API imports at a glance
- Only entities holding a UAE pharmaceutical facility or medical warehouse licence, with the corresponding EDE import permit, may import APIs
- Import permits, facility licensing, and GMP and GDP oversight transferred from MOHAP to the EDE under the 2025 law
- An API source should hold DMF or CEP documentation and GMP evidence from the manufacturing site
- Permits are generally issued per consignment, so they belong in every shipment plan
- GDP standards govern storage and handling from the moment material arrives
The consignment cycle, step by step
Once a source is approved, the import cycle itself is a repeatable discipline. Each consignment moves through the same sequence.
Approve the source
Collect the DMF or CEP documentation and the GMP evidence for the API site, and close any gaps before committing to supply.
Obtain the EDE import permit
The application is built on the proforma invoice, the product details, and the quantities. Permits are generally issued per consignment.
Ship and clear customs
Shipment documents must match the permit. The licensed importer clears the consignment through UAE customs.
Receive under GDP
Material arrives into a licensed warehouse and is held under GDP conditions, with controlled storage where the material requires it.
Deliver to the manufacturing site
Stock is released to the production site with a complete documentation trail, ready for incoming quality control.
The UAE as a regional API hub
The same infrastructure serves companies that do not manufacture in the UAE at all. International API producers and traders use the UAE as a distribution hub for the GCC and Africa, holding stock in licensed facilities, including free zone setups, and re-exporting against regional demand. The rules do not soften for a trading model: the licences, the permits, and the GDP standards are the same discipline applied to a different flow.
How we run it
We manage API supply end to end: source registration files, import permits under our own importer licence, GDP warehousing, and delivery to your site. Because we hold the licences ourselves, there is no dependency on a third party importer, and no need to build your own UAE facility before production needs the material. We are a licensed partner, not a paperwork consultancy. For scope and commercial terms, request a quotation.
Explore the full service: API import and registration in the UAE
This briefing is general information, not regulatory or legal advice. UAE requirements continue to evolve under the current law; confirm the position with the relevant authority or contact our team before acting.